한글목차

대동맥판막 협착증 시장은 2025년에 101억 7,000만 달러, 2032년에는 204억 6,000만 달러에 이를 것으로 예측되며, 2025-2032년 연평균 복합 성장률(CAGR)은 10.5%를 나타낼 전망입니다.

대동맥판막협착증은 좌심실과 대동맥을 분리하는 대동맥판막 입구가 좁아지는 질환입니다. 심장에서 주동맥(대동맥)으로의 혈류를 방해하고, 심장의 주 펌프실이 수축할 때마다 신체로 보내지는 혈액량을 감소시킵니다. 대동맥판막 협착증의 진행은 수년에 걸쳐 천천히 진행되며, 초기에는 무증상이지만 심해지면 증상이 나타납니다. 판막 입구가 더 좁아지면 심장은 제한된 판막 입구를 통해 충분한 혈액을 펌프질하기 위해 더 강하게 작동해야 하므로 심장에 추가적인 부담을 주게 됩니다. 이 때문에 치료하지 않으면 결국 심장 근육이 약해지고 손상될 수 있습니다.

시장 역학

고혈압, 비만, 당뇨병과 같은 위험인자의 유병률 증가는 세계 대동맥판막 협착증 시장의 성장에 크게 기여하고 있습니다. 대동맥판막 협착증의 일반적인 원인으로는 노화, 대동맥판막에 칼슘이 침착되어 딱딱해지는 것, 류마티스 열, 대동맥판막의 선천성 기형 등이 있습니다. 고령화, 기술 발전, 인식 개선은 예측 기간 동안 세계 대동맥판막 협착증 시장의 성장을 가속할 것으로 예측됩니다. 또한, 의료비 증가는 예측 기간 동안 세계 대동맥판막 협착증 시장의 성장을 가속할 것으로 예측됩니다. 경피적 대동맥판막 치환술(TAVR)의 확대, 신흥 시장에서의 치료 및 신약 개발, 개인 맞춤형 의료, 원격 의료 및 원격 모니터링은 예측 기간 동안 세계 대동맥판막 협착증 시장에 성장 기회를 제공할 것으로 예측됩니다.

그러나 높은 치료 비용, 제한적인 상환 정책, 가용성 및 인지도 장벽, 임상 및 시술 합병증은 예측 기간 동안 대동맥판막 협착증 시장의 성장을 저해할 것으로 예측됩니다.

본 보고서의 주요 특징

• 세계의 대동맥판막 협착증 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 예측기간(2025-2032년) 시장 규모와 CAGR을 조사하여 전해드립니다.
• 또한, 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 세계 대동맥판막 협착증 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등 다양한 매개 변수를 기반으로 작성되었습니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 대동맥판막 협착증 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 대동맥판막 협착증 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 분석 목적과 전제조건

• 분석 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제 및 동향 분석

• 시장 역학
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 발매 및 승인
• PEST 분석
• 파이프라인 분석
• Porter의 Five Forces 분석
• 인수합병(M&A) 시나리오

제4장 세계의 대동맥판막 협착증 시장 : 신형 코로나바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 세계의 대동맥판막 협착증 시장 : 유형별(2020-2032년)

• 선천성 대동맥판막 협착증
• 후천성 대동맥판막 협착증

제6장 세계의 대동맥판막 협착증 시장 : 대동맥판 유형별(2020-2032년)

• 기계식 대동맥판막
• 생체 보형물 대동맥판막

제7장 세계의 대동맥판막 협착증 시장 : 중증도별(2020-2032년)

• 경도 대동맥판막 협착증
• 중등도 대동맥판막 협착증
• 중증 대동맥판막 협착증

제8장 세계의 대동맥판막 협착증 시장 : 최종사용자별(2020-2032년)

• 병원
• 클리닉
• 외래수술센터(ASC)
• 기타

제9장 세계의 대동맥판막 협착증 시장 : 지역별(2020-2032년)

• 북미
• 미국
• 캐나다
• 라틴아메리카
• 브라질
• 멕시코
• 아르헨티나
• 기타 라틴아메리카
• 유럽
• 영국
• 독일
• 프랑스
• 이탈리아
• 스페인
• 러시아
• 기타 유럽
• 아시아태평양
• 중국
• 인도
• 일본
• 호주
• 한국
• ASEAN
• 기타 아시아태평양
• 중동
• GCC
• 이스라엘
• 기타 중동
• 아프리카
• 북아프리카
• 중앙아프리카
• 남아프리카

제10장 경쟁 구도

• Edwards Lifesciences Corporation
• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• LivaNova PLC
• CryoLife, Inc
• Braile Biomedica
• JenaValve Technology, Inc
• Meril Life Sciences Pvt. Ltd
• Micro Interventional Devices, Inc
• egnite, Inc.

제11장 섹션

• 분석 방법
• 출판사에 대해

영문목차

Aortic Stenosis Market is estimated to be valued at USD 10.17 Bn in 2025 and is expected to reach USD 20.46 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.5% from 2025 to 2032.

Aortic stenosis is a narrowing of the aortic valve opening that divides the left ventricle from the aorta. It obstructs the blood flow from the heart into the main artery (aorta) and reduces the amount of blood pumped out to the body with each contraction of the heart's main pumping chamber. Aortic stenosis progression can occur slowly over many years and asymptomatic in early stages, with symptoms developing as it becomes more severe. As the valve opening narrows further, the heart must work harder to pump enough blood through the restricted opening, putting extra strain on the heart. This can eventually weaken and damage the heart muscle if not treated.

Market Dynamics

The rising prevalence of risk factors such as high blood pressure, obesity and diabetes is significantly contributing to the growth of the global aortic stenosis market. Some of the common causes of aortic stenosis include aging, deposits of calcium on the aortic valve which makes it stiff, rheumatic fever and congenital malformations of the aortic valve. Aging population, technological advancements, and increasing awareness are anticipated to drive growth of the global aortic stenosis market over the forecast period. Moreover, rising healthcare expenditure is also expected to boost the growth of the global aortic stenosis market over the forecast period. Transcatheter aortic valve replacement (TAVR) expansion, emerging therapies and novel drug development, personalized medicine, and telemedicine and remote monitoring are expected to create growth opportunities for the global aortic stenosis market during the forecast period.

However, high cost of treatment, limited reimbursement policies, availability and awareness barriers, and clinical and procedural complications are expected to hamper growth of the aortic stenosis market over the forecast period.

Key features of the study:

• This report provides an in-depth analysis of the global aortic stenosis market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global aortic stenosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Edwards Lifesciences Corporation, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, CryoLife, Inc., Braile Biomedica, JenaValve Technology, Inc., Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, Inc., and egnite, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global aortic stenosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aortic stenosis market

Aortic Stenosis Market Detailed Segmentation:

• By Type:
  • Congenital Aortic Stenosis
  • Acquired Aortic Stenosis
• By Aortic Valve Types:
  • Mechanical Aortic Valves
  • Bioprosthetic (Tissue) Aortic Valves
• By Severity:
  • Mild Aortic Stenosis
  • Moderate Aortic Stenosis
  • Severe Aortic Stenosis
• By End User:
  • Hospital
  • Clinics
  • Ambulatory Surgical Centers
  • Others
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profile:
  • Edwards Lifesciences Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • CryoLife, Inc.
  • Braile Biomedica
  • JenaValve Technology, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Micro Interventional Devices, Inc.
  • gnite, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Aortic Valve Types
  • Market Snapshot, By Severity
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Aging Population
  • High Cost of Treatment
  • Transcatheter Aortic Valve Replacement (TAVR) Expansion
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• Pipeline Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Aortic Stenosis Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Aortic Stenosis Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Congenital Aortic Stenosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Acquired Aortic Stenosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Aortic Stenosis Market, By Aortic Valve Types, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Mechanical Aortic Valves
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Bioprosthetic (Tissue) Aortic Valves
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Aortic Stenosis Market, By Severity, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Mild Aortic Stenosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Moderate Aortic Stenosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Severe Aortic Stenosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Aortic Stenosis Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Aortic Stenosis Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021-2028
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
• U.S.
• Canada
• Lain America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2028, (US$ Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
• U.K.
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Aortic Valve Types, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Severity 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2032, (US$ Bn)
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Edwards Lifesciences Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• LivaNova PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• CryoLife, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Braile Biomedica
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• JenaValve Technology, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Meril Life Sciences Pvt. Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Micro Interventional Devices, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• egnite, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

11. Section

• Research Methodology
• About us